Navigation Links
caprotec bioanalytics Announces Issuance In Europe of All Core Patents of Its CCMS Technology
Date:2/28/2011

BERLIN, and BURLINGTON, Mass., Feb. 28, 2011 /PRNewswire/ -- caprotec bioanalytics GmbH announced today that the European Patent Office has granted the last of three core patents protecting its proprietary and revolutionary Capture Compound Mass Spectrometry (CCMS) technology.  

CCMS offers a novel and direct way to investigate small molecule - protein interactions resulting in a significant functional reduction of proteome complexity. The core of the CCMS technology consists of tri-functional small molecules called Capture Compounds™.  These Capture Compounds enable the direct isolation and identification of selected proteins, including membrane proteins, out of any complex biological sample.

An important application of the CCMS technology is to profile small molecule drug - protein interactions in the human proteome to discover or confirm relevant protein drug targets, the mode of drug action, and off-target proteins potentially causing adverse side effects in humans.

The newly granted European Patent No. EP 1583972 titled "Methods for Identifying Drug Non-targets" covers the use of CCMS technology for lead optimization and risk assessment of candidate drugs to make a go or no-go decision to enter the clinical trial phase.  The European Patent No.  EP  1485707 titled "Compounds and Methods for Analyzing the Proteome" covers Capture Compounds and methods to discover protein biomarkers for diagnostic applications. European Patent No. EP 1502102 titled "Compounds and Methods for Analyzing the Proteome" covers an array-based application of CCMS technology.  Equivalent patents have been issued in many major countries.

"We are pleased about the grant of the last of our three core CCMS patents in Europe, which protect our proprietary technology and endorse the uniqueness of this powerful proteome analysis technology," states Prof. Dr. Hubert Koester, Founder and Chief Executive Officer of caprot
'/>"/>

SOURCE caprotec bioanalytics GmbH
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. caprotec bioanalytics Announces the Successful Completion of a Collaborative Research Project With Roche
2. caprotec bioanalytics Announces Commercial Launch of Three New caproKits™ for Applications in Functional Proteomics and Drug Development
3. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
4. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
5. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
6. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
7. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
8. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
9. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
10. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
11. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2015)... BerGenBio AS ("BerGenBio" or the ... has appointed Hilde Furberg and Dr ... of Directors, effective immediately. Hilde Furberg ... and biotech and is currently Senior Vice President Rare ... role was Vice President and General Manager of Nordic ...
(Date:8/31/2015)...  DICOM Grid,  the #1 medical image exchange ... as a semifinalist for a Minnie award for ... are sponsored by Auntminnie.com, a comprehensive community website ... imaging industry.  Since 1999, the "Minnies" have provided ... contributions of their peers. Nominations are made by ...
(Date:8/31/2015)... 2015 Thousands of people will peacefully demonstrate ... opioid addiction epidemic at dozens of rallies across the ... the United States has experienced ... opioids and heroin, yet the President has never once ... letter to President Obama , rally organizers compared ...
Breaking Medicine Technology:BerGenBio Appoints Non-Executive Directors 2DG Suite Nabs "Minnies" Nomination for "Best New Radiology Software" 2Obama Administration's Neglect of Opioid Crisis Prompts Rallies in Many States 2
(Date:9/1/2015)... New York, New York (PRWEB) , ... September 01, 2015 , ... ... of Zecurion Zlock Mac , its groundbreaking new version of endpoint DLP developed ... testing of Zlock Mac, in which more than 100 IT and information security professionals ...
(Date:9/1/2015)... ... September 01, 2015 , ... SC&H Group, a leading ... includes being named a “Best of the Best” firm in the U.S., as well ... the “Best of the Best” in the U.S., selected exclusively on performance in specific ...
(Date:9/1/2015)... ... September 01, 2015 , ... CanAm Enterprises LLC, (“CanAm”) ... permanent green cards (I-829 petition approval) from the USCIS through an investment in ... step of the EB-5 visa process for immigrant investors to become lawful permanent ...
(Date:9/1/2015)... , ... September 01, 2015 , ... ... popular VitaSkin™ collection of products, the VitaSkin™ Exfoliating Peels. This revolutionary collection of ... pillars: Firm, Bright, Calm, and Clear. , Formulated with alpha hydroxy acids ...
(Date:9/1/2015)... ... September 01, 2015 , ... ... information about new patients directly from Practice Perfect to FOTO enabling cost and ... , Steven Presement, President of Practice Perfect, stated "FOTO is ...
Breaking Medicine News(10 mins):Health News:Zecurion Announces Endpoint Security for Mac 2Health News:SC&H Group Receives Multiple Honors from INSIDE Public Accounting 2Health News:CanAm Enterprises Reaches Another Milestone with More Than 1,500 I-829 Petition Approvals 2Health News:Éminence Organic Skin Care Introduces Results-Oriented Exfoliating Peels for Every Skin Type 2Health News:Éminence Organic Skin Care Introduces Results-Oriented Exfoliating Peels for Every Skin Type 3Health News:FOTO Announces New Integration Partnership with Practice Perfect 2
... Footprint at DaVita,s Six Corporate Business OfficesEL SEGUNDO, Calif., ... ), a leading provider of kidney care services for ... that the company is the first FORTUNE 500 healthcare ... Green Power Partnership program. Joining this program is part ...
... 2009PURCHASE, N.Y., May 12 Nutrition 21, Inc. (Nasdaq: ... nutritional supplements under the Iceland Health(R), Chromax(R) and Diabetes ... improve cardiovascular health, enhance memory and reduce chronic joint ... and the first nine months of fiscal year 2009 ...
... JENA, Germany, May 12 Occlutech, the leading European,developer of ... for its new generation ASD and PFO occluders, the Figulla ... and PFO occluders encompass a new innovative,delivery system, making the ... is facilitated by the ability of the delivery,system to allow ...
... PET/CT Viewer to Provide High Quality Viewing Capability on a ... ... PETLinQ LLC, a leading radiology solutions provider , is proud to ... pure thin client web based application created for the viewing of full ...
... care will present technology and admissions educational sessions for ACHCA ... ... May 12, 2009 --Patient Placement Systems, the leading provider of ... it will exhibit and present two sessions at the American ...
... during the earthquake require long-term specialized care to properly heal ... ... China (Vocus) May 12, 2009 -- On the one-year anniversary ... Project HOPE , an international health education and humanitarian assistance ...
Cached Medicine News:Health News:DaVita Becomes the First FORTUNE 500 Healthcare Services Company to Join the EPA Green Power Partnership 2Health News:DaVita Becomes the First FORTUNE 500 Healthcare Services Company to Join the EPA Green Power Partnership 3Health News:Nutrition 21 Announces Financial Results for Q3 Fiscal 2009 2Health News:Nutrition 21 Announces Financial Results for Q3 Fiscal 2009 3Health News:Nutrition 21 Announces Financial Results for Q3 Fiscal 2009 4Health News:Nutrition 21 Announces Financial Results for Q3 Fiscal 2009 5Health News:Nutrition 21 Announces Financial Results for Q3 Fiscal 2009 6Health News:Nutrition 21 Announces Financial Results for Q3 Fiscal 2009 7Health News:PETLinQ to Debut Pure Web Based PET/CT Fusion Viewer at June 2009 SNM Conference 2Health News:Patient Placement Systems Presenting Two Sessions at ACHCA 2009 Convocation 2Health News:Patient Placement Systems Presenting Two Sessions at ACHCA 2009 Convocation 3Health News:Project HOPE Launches Rehabilitation Program to Address Needs of Thousands Recovering from Injuries Sustained During the May 12, 2008 Earthquake 2Health News:Project HOPE Launches Rehabilitation Program to Address Needs of Thousands Recovering from Injuries Sustained During the May 12, 2008 Earthquake 3
The CH 2000 Cardiac Diagnostic system is a fully featured stress testing system that can include Microvolt T-Wave Alternans (MTWA) testing capability as an add-on feature. , ,Interfaces with Tra...
... The Volk G-1 trabeculum provides the highest ... Perfect for viewing and treating the trabecular meshwork. ... of the anterior chamber angle while the central ... view the posterior pole for signs of glaucoma ...
... AFX (Air Fluid eXchange) Lens ... designed for use in an ... its use as a primary ... low profile and sutureless design ...
... The 45° Prism is ... pathologies and are recommended ... (PDR, BRVO etc.) and ... can be used for ...
Medicine Products: